Zyryanov, S. K., & Dyakov, I. N. Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy. IRBIS LLC.
Chicago Style (17th ed.) CitationZyryanov, S. K., and I. N. Dyakov. Updated Pharmacoeconomic Analysis of Atesolizumab Efficiency Compared with Other PD-1 Inhibitors in Patients with Advanced Non-small Cell Lung Cancer After Chemotherapy. IRBIS LLC.
MLA (9th ed.) CitationZyryanov, S. K., and I. N. Dyakov. Updated Pharmacoeconomic Analysis of Atesolizumab Efficiency Compared with Other PD-1 Inhibitors in Patients with Advanced Non-small Cell Lung Cancer After Chemotherapy. IRBIS LLC.
Warning: These citations may not always be 100% accurate.